Skip to Content

ER 4 2.25 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)

Pill with imprint ER 4 2.25 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 4 2.25

Pramipexole Dihydrochloride Extended-Release

Imprint:
ER 4 2.25
Strength:
2.25 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0211

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide